 | • レポートコード：QYR9ST01890 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のアトピー性皮膚炎薬市場について調査・分析し、以下の構成でお届け致します。アトピー性皮膚炎薬の種類別には、注射可能ROA、経口ROA、外用薬ROAに、用途別には、病院、診療所に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別アトピー性皮膚炎薬売上データ ・地域別アトピー性皮膚炎薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別アトピー性皮膚炎薬市場規模：注射可能ROA、経口ROA、外用薬ROA ・用途別アトピー性皮膚炎薬市場規模：病院、診療所 ・主要メーカーの企業情報：LEO Pharma、Mylan、Valeant、Bayer HealthCare、Encore Dermatology ・アトピー性皮膚炎薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized).One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated with food allergy. It has been observed that these allergies mainly result from the cow’s milk, chicken eggs, peanuts, wheat, soy, nuts, and fish.
The global Atopic Dermatitis Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Atopic Dermatitis Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Atopic Dermatitis Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Atopic Dermatitis Drugs in these regions.
This research report categorizes the global Atopic Dermatitis Drugs market by top players/brands, region, type and end user. This report also studies the global Atopic Dermatitis Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
LEO Pharma
Mylan
Valeant
Bayer HealthCare
Encore Dermatology
Market size by Product
Injectable ROA
Oral ROA
Tropical ROA
Market size by End User
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Atopic Dermatitis Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Atopic Dermatitis Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Atopic Dermatitis Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Atopic Dermatitis Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Atopic Dermatitis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Atopic Dermatitis Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Atopic Dermatitis Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Atopic Dermatitis Drugs Market Size Growth Rate by Product
1.4.2 Injectable ROA
1.4.3 Oral ROA
1.4.4 Tropical ROA
1.5 Market by End User
1.5.1 Global Atopic Dermatitis Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Atopic Dermatitis Drugs Market Size
2.1.1 Global Atopic Dermatitis Drugs Revenue 2014-2025
2.1.2 Global Atopic Dermatitis Drugs Sales 2014-2025
2.2 Atopic Dermatitis Drugs Growth Rate by Regions
2.2.1 Global Atopic Dermatitis Drugs Sales by Regions
2.2.2 Global Atopic Dermatitis Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Atopic Dermatitis Drugs Sales by Manufacturers
3.1.1 Atopic Dermatitis Drugs Sales by Manufacturers
3.1.2 Atopic Dermatitis Drugs Sales Market Share by Manufacturers
3.1.3 Global Atopic Dermatitis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Atopic Dermatitis Drugs Revenue by Manufacturers
3.2.1 Atopic Dermatitis Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Atopic Dermatitis Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Atopic Dermatitis Drugs Price by Manufacturers
3.4 Atopic Dermatitis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Atopic Dermatitis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Atopic Dermatitis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Atopic Dermatitis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Atopic Dermatitis Drugs Sales by Product
4.2 Global Atopic Dermatitis Drugs Revenue by Product
4.3 Atopic Dermatitis Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Atopic Dermatitis Drugs Breakdown Data by End User
6 North America
6.1 North America Atopic Dermatitis Drugs by Countries
6.1.1 North America Atopic Dermatitis Drugs Sales by Countries
6.1.2 North America Atopic Dermatitis Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Atopic Dermatitis Drugs by Product
6.3 North America Atopic Dermatitis Drugs by End User
7 Europe
7.1 Europe Atopic Dermatitis Drugs by Countries
7.1.1 Europe Atopic Dermatitis Drugs Sales by Countries
7.1.2 Europe Atopic Dermatitis Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Atopic Dermatitis Drugs by Product
7.3 Europe Atopic Dermatitis Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Atopic Dermatitis Drugs by Countries
8.1.1 Asia Pacific Atopic Dermatitis Drugs Sales by Countries
8.1.2 Asia Pacific Atopic Dermatitis Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Atopic Dermatitis Drugs by Product
8.3 Asia Pacific Atopic Dermatitis Drugs by End User
9 Central & South America
9.1 Central & South America Atopic Dermatitis Drugs by Countries
9.1.1 Central & South America Atopic Dermatitis Drugs Sales by Countries
9.1.2 Central & South America Atopic Dermatitis Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Atopic Dermatitis Drugs by Product
9.3 Central & South America Atopic Dermatitis Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Atopic Dermatitis Drugs by Countries
10.1.1 Middle East and Africa Atopic Dermatitis Drugs Sales by Countries
10.1.2 Middle East and Africa Atopic Dermatitis Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Atopic Dermatitis Drugs by Product
10.3 Middle East and Africa Atopic Dermatitis Drugs by End User
11 Company Profiles
11.1 LEO Pharma
11.1.1 LEO Pharma Company Details
11.1.2 Company Business Overview
11.1.3 LEO Pharma Atopic Dermatitis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 LEO Pharma Atopic Dermatitis Drugs Products Offered
11.1.5 LEO Pharma Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Company Business Overview
11.2.3 Mylan Atopic Dermatitis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Mylan Atopic Dermatitis Drugs Products Offered
11.2.5 Mylan Recent Development
11.3 Valeant
11.3.1 Valeant Company Details
11.3.2 Company Business Overview
11.3.3 Valeant Atopic Dermatitis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Valeant Atopic Dermatitis Drugs Products Offered
11.3.5 Valeant Recent Development
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Details
11.4.2 Company Business Overview
11.4.3 Bayer HealthCare Atopic Dermatitis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bayer HealthCare Atopic Dermatitis Drugs Products Offered
11.4.5 Bayer HealthCare Recent Development
11.5 Encore Dermatology
11.5.1 Encore Dermatology Company Details
11.5.2 Company Business Overview
11.5.3 Encore Dermatology Atopic Dermatitis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Encore Dermatology Atopic Dermatitis Drugs Products Offered
11.5.5 Encore Dermatology Recent Development
12 Future Forecast
12.1 Atopic Dermatitis Drugs Market Forecast by Regions
12.1.1 Global Atopic Dermatitis Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Atopic Dermatitis Drugs Revenue Forecast by Regions 2019-2025
12.2 Atopic Dermatitis Drugs Market Forecast by Product
12.2.1 Global Atopic Dermatitis Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Atopic Dermatitis Drugs Revenue Forecast by Product 2019-2025
12.3 Atopic Dermatitis Drugs Market Forecast by End User
12.4 North America Atopic Dermatitis Drugs Forecast
12.5 Europe Atopic Dermatitis Drugs Forecast
12.6 Asia Pacific Atopic Dermatitis Drugs Forecast
12.7 Central & South America Atopic Dermatitis Drugs Forecast
12.8 Middle East and Africa Atopic Dermatitis Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Atopic Dermatitis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Atopic Dermatitis Drugs Product Picture
Table Atopic Dermatitis Drugs Market Segments
Table Key Manufacturers Atopic Dermatitis Drugs Covered
Table Global Atopic Dermatitis Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Atopic Dermatitis Drugs Sales Market Share by Product 2014-2025
Figure Injectable ROA Product Picture
Table Major Manufacturers of Injectable ROA
Figure Oral ROA Product Picture
Table Major Manufacturers of Oral ROA
Figure Tropical ROA Product Picture
Table Major Manufacturers of Tropical ROA
Table Global Atopic Dermatitis Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Atopic Dermatitis Drugs Report Years Considered
Figure Global Atopic Dermatitis Drugs Market Size 2014-2025 (Million US$)
Figure Global Atopic Dermatitis Drugs Sales 2014-2025 (K Units)
Table Global Atopic Dermatitis Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Atopic Dermatitis Drugs Sales by Regions 2014-2019 (K Units)
Table Global Atopic Dermatitis Drugs Sales Market Share by Regions 2014-2019
Figure Global Atopic Dermatitis Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Atopic Dermatitis Drugs Sales Market Share by Regions
Table Global Atopic Dermatitis Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Atopic Dermatitis Drugs Revenue Market Share by Regions 2014-2019
Figure Global Atopic Dermatitis Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Atopic Dermatitis Drugs Revenue Market Share by Regions
Table Global Atopic Dermatitis Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Atopic Dermatitis Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Atopic Dermatitis Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Atopic Dermatitis Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Atopic Dermatitis Drugs Revenue Share by Manufacturers (2014-2019)
Figure Atopic Dermatitis Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Atopic Dermatitis Drugs Price (2014-2019) (USD/Unit)
Table Atopic Dermatitis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Atopic Dermatitis Drugs Product Type
Table Date of International Manufacturers Enter into Atopic Dermatitis Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Atopic Dermatitis Drugs Sales by Product (2014-2019) (K Units)
Table Global Atopic Dermatitis Drugs Sales Share by Product (2014-2019)
Figure Global Atopic Dermatitis Drugs Sales Market Share by Product (2014-2019)
Figure Global Atopic Dermatitis Drugs Sales Market Share by Product in 2018
Table Global Atopic Dermatitis Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Atopic Dermatitis Drugs Revenue Share by Product (2014-2019)
Figure Global Atopic Dermatitis Drugs Revenue Market Share by Product (2014-2019)
Figure Global Atopic Dermatitis Drugs Revenue Market Share by Product in 2018
Table Atopic Dermatitis Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Atopic Dermatitis Drugs Sales by End User (2014-2019) (K Units)
Table Global Atopic Dermatitis Drugs Sales Share by End User (2014-2019)
Figure Global Sales Atopic Dermatitis Drugs Market Share by End User (2014-2019)
Figure Global Sales Atopic Dermatitis Drugs Market Share by End User in 2018
Figure North America Atopic Dermatitis Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Atopic Dermatitis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Atopic Dermatitis Drugs Sales by Countries (2014-2019) (K Units)
Table North America Atopic Dermatitis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Atopic Dermatitis Drugs Sales Market Share by Countries
Table North America Atopic Dermatitis Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Atopic Dermatitis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Atopic Dermatitis Drugs Revenue Market Share by Countries
Figure United States Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Atopic Dermatitis Drugs Sales by Product (2014-2019) (K Units)
Table North America Atopic Dermatitis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Atopic Dermatitis Drugs Market Share by Product
Table North America Atopic Dermatitis Drugs Sales by End User (2014-2019) (K Units)
Table North America Atopic Dermatitis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Atopic Dermatitis Drugs Market Share by End User
Figure Europe Atopic Dermatitis Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Atopic Dermatitis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Atopic Dermatitis Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Atopic Dermatitis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Atopic Dermatitis Drugs Sales Market Share by Countries
Table Europe Atopic Dermatitis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Atopic Dermatitis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Atopic Dermatitis Drugs Revenue Market Share by Countries
Figure Germany Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Atopic Dermatitis Drugs Sales by Product (2014-2019) (K Units)
Table Europe Atopic Dermatitis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Atopic Dermatitis Drugs Market Share by Product
Table Europe Atopic Dermatitis Drugs Sales by End User (2014-2019) (K Units)
Table Europe Atopic Dermatitis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Atopic Dermatitis Drugs Market Share by End User
Figure Asia Pacific Atopic Dermatitis Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Atopic Dermatitis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Atopic Dermatitis Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Countries
Table Asia Pacific Atopic Dermatitis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Atopic Dermatitis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Atopic Dermatitis Drugs Revenue Market Share by Countries
Figure China Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Atopic Dermatitis Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Atopic Dermatitis Drugs Market Share by Product
Table Asia Pacific Atopic Dermatitis Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Atopic Dermatitis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Atopic Dermatitis Drugs Market Share by End User
Figure Central & South America Atopic Dermatitis Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Atopic Dermatitis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Atopic Dermatitis Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Atopic Dermatitis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Atopic Dermatitis Drugs Sales Market Share by Countries
Table Central & South America Atopic Dermatitis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Atopic Dermatitis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Atopic Dermatitis Drugs Revenue Market Share by Countries
Figure Brazil Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Atopic Dermatitis Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Atopic Dermatitis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Atopic Dermatitis Drugs Market Share by Product
Table Central & South America Atopic Dermatitis Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Atopic Dermatitis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Atopic Dermatitis Drugs Market Share by End User
Figure Middle East and Africa Atopic Dermatitis Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Atopic Dermatitis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Atopic Dermatitis Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Countries
Table Middle East and Africa Atopic Dermatitis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Atopic Dermatitis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Atopic Dermatitis Drugs Revenue Market Share by Countries
Figure GCC Countries Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Atopic Dermatitis Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Atopic Dermatitis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Atopic Dermatitis Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Atopic Dermatitis Drugs Market Share by Product
Table Middle East and Africa Atopic Dermatitis Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Atopic Dermatitis Drugs Market Share by End User
Table LEO Pharma Company Details
Table LEO Pharma Atopic Dermatitis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table LEO Pharma Recent Development
Table Mylan Company Details
Table Mylan Atopic Dermatitis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Valeant Company Details
Table Valeant Atopic Dermatitis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Recent Development
Table Bayer HealthCare Company Details
Table Bayer HealthCare Atopic Dermatitis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer HealthCare Recent Development
Table Encore Dermatology Company Details
Table Encore Dermatology Atopic Dermatitis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Encore Dermatology Recent Development
Table Global Atopic Dermatitis Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Atopic Dermatitis Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Atopic Dermatitis Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Atopic Dermatitis Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Atopic Dermatitis Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Atopic Dermatitis Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Atopic Dermatitis Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Atopic Dermatitis Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Atopic Dermatitis Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Atopic Dermatitis Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Atopic Dermatitis Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Atopic Dermatitis Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Atopic Dermatitis Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Atopic Dermatitis Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Atopic Dermatitis Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Atopic Dermatitis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Atopic Dermatitis Drugs Value Chain
Table Atopic Dermatitis Drugs Customers List
Table Atopic Dermatitis Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
アトピー性皮膚炎治療の世界市場：市場規模・現状・予測 Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with a characteristic phenotype and typically distributed skin lesions.In 2018, the global …- アトピー性皮膚炎治療の世界市場：市場規模・現状・予測 Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with a characteristic phenotype and typically distributed skin lesions.In 2018, the global …
- 犬のアトピー性皮膚炎治療の世界市場：市場規模・現状・予測 Canine atopic dermatitis is a problem that is related to the skin, which when exposed to the allergens results in allergic symptoms.In 2018, the global Canine Atopic Dermatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% …
- 犬のアトピー性皮膚炎治療の世界市場：市場規模・現状・予測 Canine atopic dermatitis is a problem that is related to the skin, which when exposed to the allergens results in allergic symptoms.In 2018, the global Canine Atopic Dermatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% …
- アトピー性皮膚炎治療の世界市場：市場規模・現状・予測 Atopic dermatitis is a chronic disease that causes inflammation of the skin and results in red, itchy, swollen, and cracked skin. In 2018, the global Atopic Dermatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 20…